Product Name :Uroplakin 3a monoclonal antibody
Application_all :IHC (1/100 - 1/300)
Background :The asymmetric unit membrane (AUM) forms numerous plaques, which cover the apical surface of the urothelium. These plaques are thought to strengthen the urothelium and reduce the risk of rupturing during bladder distention. They are composed of four major integral membrane proteins called uroplakins (UP). The uroplakin family comprises UPIa, UPIb, UPII and UPIII. Family members are conserved among several species, including human, mouse, rat, rabbit, canine, porcine and ovine. UPIa and UPIb form tightly packed structures with UPII and UPIII, respectively. This pairing is required for normal urothelial plaque formation and is regulated by proteolytic processing of the uroplakin proteins. Uroplakins are expressed in normal urothelium and are used as specific markers of urothelial differentiation. They are also expressed in a majority of transitional cell carcinomas of the bladder (TCCs), which make the uroplakins a useful marker for detecting bladder cancer metastasis and for staging and monitoring chemotherapeutic response.
Product :Mouse IgG1. Liquid in PBS containing 50% glycerol, 0.2% BSA and 0.01% sodium azide.
Purification&Purity :The antibody was affinity-purified from mouse antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
Storage&Stability :Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity :Recognizes endogenous levels of Uroplakin 3a protein.
Note :For research use only, not for use in diagnostic procedure.
Alternative Name :UPK3; Uroplakin-3a; UP3a; Uroplakin III; UPIII
Immunogen :KLH-conjugated synthetic peptide encompassing a sequence within human Uroplakin 3a. The exact sequence is proprietary.
Modification :Unmodification
